Coffee, Caffeine, and Health Outcomes: An Umbrella Review

Annual Review of Nutrition

Volumn 37, Issue , 2017, Pages 131-156

  Grosso, Giuseppe ^a,b   Godos, Justyna ^a,c   Galvano, Fabio ^c   Giovannucci, Edward L ^d,e  

^a Integrated Cancer Registry of Catania Messina Siracusa Enna ^*  (Italy)

^b ST JOHN S COLLEGE   (United Kingdom)

^c UNIVERSITY OF CATANIA   (Italy)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Caffeine; Cancer; Cardiovascular disease; Coffee; Diabetes; Neurodegenerative disease

Indexed keywords

CAFFEINE; COFFEE;

CARDIOVASCULAR DISEASES; COFFEE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMAN; MALE; META ANALYSIS; NEOPLASMS; NEURODEGENERATIVE DISEASES; OBSERVATIONAL STUDY; PREGNANCY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK;

CAFFEINE; CARDIOVASCULAR DISEASES; COFFEE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; NEOPLASMS; NEURODEGENERATIVE DISEASES; OBSERVATIONAL STUDIES AS TOPIC; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK;

EID: 85017132703     PISSN: 01999885     EISSN: 15454312     Source Type: Book Series    
DOI: 10.1146/annurev-nutr-071816-064941     Document Type: Review

References (156)

1. Bai K, Cai Q, Jiang Y, Lv L. 2016. Coffee consumption and risk of hepatocellular carcinoma: A metaanalysis of eleven epidemiological studies. Onco Targets Ther. 9:4369-75
2. Bohn SK, Blomhoff R, Paur I. 2014. Coffee and cancer risk, epidemiological evidence, and molecular mechanisms. Mol. Nutr. Food Res. 58:915-30
3. Botelho F, Lunet N, Barros H. 2006. Coffee and gastric cancer: Systematic review and meta-analysis. Cad. Saude Publica 22:889-900
4. Braem MG, Onland-Moret NC, Schouten LJ, Tjonneland A, Hansen L, et al. 2012. Coffee and tea consumption and the risk of ovarian cancer: A prospective cohort study and updated meta-analysis. Am. J. Clin. Nutr. 95:1172-81
5. Bravi F, Bosetti C, Tavani A, Bagnardi V, Gallus S, et al. 2007. Coffee drinking and hepatocellular carcinoma risk: A meta-analysis. Hepatology 46:430-35
6. Bravi F, Bosetti C, Tavani A, Gallus S, La Vecchia C. 2013. Coffee reduces risk for hepatocellular carcinoma: An updated meta-analysis. Clin. Gastroenterol. Hepatol. 11:1413-21
7. Bravi F, Scotti L, Bosetti C, Gallus S, Negri E, et al. 2009. Coffee drinking and endometrial cancer risk: A metaanalysis of observational studies. Am. J. Obstet. Gynecol. 200:130-35
8. Bravi F, Tavani A, Bosetti C, Boffetta P, La Vecchia C. 2017. Coffee and the risk of hepatocellular carcinoma and chronic liver disease: A systematic review and meta-analysis of prospective studies. Eur. J. Cancer Prev. In press. http://dx.doi.org/10.1097/CEJ.0000000000000252
9. Brent RL, Christian MS, Diener RM. 2011. Evaluation of the reproductive and developmental risks of caffeine. Birth Defects Res. B Dev. Reprod. Toxicol. 92:152-87
10. Brown OI, Allgar V, Wong KY. 2016. Coffee reduces the risk of death after acute myocardial infarction: A meta-analysis. Coron. Artery Dis. 27:566-72
11. Buscemi S, Marventano S, Antoci M, Cagnetti A, Castorina G, et al. 2016. Coffee and metabolic impairment: An updated review of epidemiological studies. NFS J. 3:1-7
12. Cai L, Ma D, Zhang Y, Liu Z, Wang P. 2012. The effect of coffee consumption on serum lipids: A meta-analysis of randomized controlled trials. Eur. J. Clin. Nutr. 66:872-77
13. Caini S, Cattaruzza S, Bendinelli B, Tosti G, Masala G, et al. 2016. Coffee, tea and caffeine intake and the risk of non-melanoma skin cancer: A review of the literature and meta-analysis. Eur. J. Nutr. 56:1-12
14. Caldeira D, Martins C, Alves LB, Pereira H, Ferreira JJ, Costa J. 2013. Caffeine does not increase the risk of atrial fibrillation: A systematic review andmeta-analysis of observational studies. Heart 99:1383-89
15. Cao S, Liu L, Yin X, Wang Y, Liu J, Lu Z. 2014. Coffee consumption and risk of prostate cancer: A meta-analysis of prospective cohort studies. Carcinogenesis 35:256-61
16. Chen J, Long S. 2014. Tea and coffee consumption and risk of laryngeal cancer: A systematic review meta-analysis. PLOS ONE 9:e112006
17. Chen LW, Wu Y, Neelakantan N, Chong MF, Pan A, van Dam RM. 2014. Maternal caffeine intake during pregnancy is associated with risk of low birth weight: A systematic review and dose-response meta-analysis. BMC Med. 12:174
18. Chen LW, Wu Y, Neelakantan N, Chong MF, Pan A, van Dam RM. 2016. Maternal caffeine intake during pregnancy and risk of pregnancy loss: A categorical and dose-response meta-analysis of prospective studies. Public Health Nutr. 19:1233-44
19. Chen S, Teoh NC, Chitturi S, Farrell GC. 2014. Coffee and non-alcoholic fatty liver disease: Brewing evidence for hepatoprotection? J. Gastroenterol. Hepatol. 29:435-41
20. Cheng J, Su H, Zhu R, Wang X, Peng M, et al. 2014. Maternal coffee consumption during pregnancy and risk of childhood acute leukemia: A metaanalysis. Am. J. Obstet. Gynecol. 210:151.e1-10
21. Cheng M, Hu Z, Lu X, Huang J, Gu D. 2014. Caffeine intake and atrial fibrillation incidence: Dose response meta-analysis of prospective cohort studies. Can. J. Cardiol. 30:448-54
22. Chiaffarino F, Bravi F, Cipriani S, Parazzini F, Ricci E, et al. 2014. Coffee and caffeine intake and risk of endometriosis: A meta-analysis. Eur. J. Nutr. 53:1573-79
23. Colussi G, De Ferrari ME, Brunati C, Civati G. 2000. Medical prevention and treatment of urinary stones. J. Nephrol. 13(Suppl. 3):S65-70
24. Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H. 2006. Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA 295:1135-41
25. Costa J, Lunet N, Santos C, Santos J, Vaz-Carneiro A. 2010. Caffeine exposure and the risk of Parkinson's disease: A systematic review and meta-analysis of observational studies. J. Alzheimers Dis. 20(Suppl. 1):S221-38
26. Crippa A, Discacciati A, Larsson SC, Wolk A, Orsini N. 2014. Coffee consumption and mortality from all causes, cardiovascular disease, and cancer: A dose-response meta-analysis. Am. J. Epidemiol. 180:763-75
27. Deng W, Yang H, Wang J, Cai J, Bai Z, et al. 2016. Coffee consumption and the risk of incident gastric cancer- A meta-analysis of prospective cohort studies. Nutr. Cancer 68:40-47
28. Ding M, Bhupathiraju SN, Chen M, van Dam RM, Hu FB. 2014. Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: A systematic review and a dose-response meta-analysis. Diabetes Care 37:569-86
29. Ding M, Bhupathiraju SN, Satija A, van Dam RM, Hu FB. 2014. Long-term coffee consumption and risk of cardiovascular disease: A systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation 129:643-59
30. Discacciati A, Orsini N, Wolk A. 2014. Coffee consumption and risk of nonaggressive, aggressive and fatal prostate cancer- A dose-response meta-analysis. Ann. Oncol. 25:584-91
31. Dong J, Zou J, Yu XF. 2011. Coffee drinking and pancreatic cancer risk: A meta-analysis of cohort studies. World J. Gastroenterol. 17:1204-10
32. Galarraga V, Boffetta P. 2016. Coffee drinking and risk of lung cancer-ameta-analysis. Cancer Epidemiol. Biomarkers Prev. 25:951-57
33. Galeone C, Turati F, La Vecchia C, Tavani A. 2010. Coffee consumption and risk of colorectal cancer: A meta-analysis of case-control studies. Cancer Causes Control 21:1949-59
34. Gan Y, Wu J, Zhang S, Li L, Cao S, et al. 2017. Association of coffee consumption with risk of colorectal cancer: A meta-analysis of prospective cohort studies. Oncotarget 8:18699-711
35. Giovannucci E. 1998. Meta-analysis of coffee consumption and risk of colorectal cancer. Am. J. Epidemiol. 147:1043-52
36. Godos J, Pluchinotta FR, Marventano S, Buscemi S, Li Volti G, et al. 2014. Coffee components and cardiovascular risk: Beneficial and detrimental effects. Int. J. Food Sci. Nutr. 65:925-36
37. Greenland S. 1993. A meta-analysis of coffee, myocardial infarction, and coronary death. Epidemiology 4:366-74
38. Greenwood DC, Thatcher NJ, Ye J, Garrard L, Keogh G, et al. 2014. Caffeine intake during pregnancy and adverse birth outcomes: A systematic review and dose-response meta-analysis. Eur. J. Epidemiol. 29:725-34
39. Grosso G, Micek A, Castellano S, Pajak A, Galvano F. 2016. Coffee, tea, caffeine and risk of depression: A systematic review and dose-response meta-analysis of observational studies. Mol. Nutr. Food Res. 60:223-34
40. Hernan MA, Takkouche B, Caamano-Isorna F, Gestal-Otero JJ. 2002.Ameta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann. Neurol. 52:276-84
41. Higdon JV, Frei B. 2006. Coffee and health: A review of recent human research. Crit. Rev. Food Sci. Nutr. 46:101-23
42. Higgins LG, Cavin C, Itoh K, Yamamoto M, Hayes JD. 2008. Induction of cancer chemopreventive enzymes by coffee is mediated by transcription factor Nrf2. Evidence that the coffee-specific diterpenes cafestol and kahweol confer protection against acrolein. Toxicol. Appl. Pharmacol. 226:328-37
43. Huang TB, Guo ZF, Zhang XL, Zhang XP, Liu H, et al. 2014. Coffee consumption and urologic cancer risk: A meta-analysis of cohort studies. Int. Urol. Nephrol. 46:1481-93
44. Huber WW, Parzefall W. 2005. Modification of N-acetyltransferases and glutathione S-transferases by coffee components: Possible relevance for cancer risk. Methods Enzymol. 401:307-41
45. Huxley R, Lee CM, Barzi F, Timmermeister L, Czernichow S, et al. 2009. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: A systematic review with metaanalysis. Arch. Intern. Med. 169:2053-63
46. Inoue M, Tsugane S. 2012. Insulin resistance and cancer: Epidemiological evidence. Endocr. Relat. Cancer 19:F1-8
47. Jahanfar S, Jaafar SH. 2015. Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcome. Cochrane Database Syst. Rev. 6:CD006965
48. Je Y, Giovannucci E. 2012. Coffee consumption and risk of endometrial cancer: Findings from a large up-to-date meta-analysis. Int. J. Cancer 131:1700-10
49. Je Y, Giovannucci E. 2014. Coffee consumption and totalmortality: Ameta-analysis of twenty prospective cohort studies. Br. J. Nutr. 111:1162-73
50. Je Y, Liu W, Giovannucci E. 2009. Coffee consumption and risk of colorectal cancer: A systematic review and meta-analysis of prospective cohort studies. Int. J. Cancer 124:1662-68
51. Jee SH, He J, Whelton PK, Suh I, Klag MJ. 1999. The effect of chronic coffee drinking on blood pressure: A meta-analysis of controlled clinical trials. Hypertension 33:647-52
52. Jiang W, Wu Y, Jiang X. 2013. Coffee and caffeine intake and breast cancer risk: An updated dose-response meta-analysis of 37 published studies. Gynecol. Oncol. 129:620-29
53. Jiang X, Zhang D, Jiang W. 2014. Coffee and caffeine intake and incidence of type 2 diabetes mellitus: A meta-analysis of prospective studies. Eur. J. Nutr. 53:25-38
54. Kawachi I, Colditz GA, Stone CB. 1994. Does coffee drinking increase the risk of coronary heart disease? Results from a meta-analysis. Br. Heart J. 72:269-75
55. Kennedy OJ, Roderick P, Buchanan R, Fallowfield JA, Hayes PC, Parkes J. 2016. Systematic review with meta-analysis: Coffee consumption and the risk of cirrhosis. Aliment. Pharmacol. Ther. 43:562-74
56. Kim B, Nam Y, Kim J, Choi H, Won C. 2012. Coffee consumption and stroke risk: A meta-analysis of epidemiologic studies. Korean J. Fam. Med. 33:356-65
57. Kim J, Oh SW, Myung SK, Kwon H, Lee C, et al. 2014. Association between coffee intake and gastroesophageal reflux disease: A meta-analysis. Dis. Esophagus 27:311-17
58. Kim YS, Kwak SM, Myung SK. 2015. Caffeine intake from coffee or tea and cognitive disorders: A meta-analysis of observational studies. Neuroepidemiology 44:51-63
59. Kua KP, Lee SW. 2017. Systematic review and meta-analysis of clinical outcomes of early caffeine therapy in preterm neonates. Br. J. Clin. Pharmacol. 83:180-191
60. Larsson SC, Drca N, Jensen-Urstad M, Wolk A. 2015. Coffee consumption is not associated with increased risk of atrial fibrillation: Results from two prospective cohorts and a meta-analysis. BMC Med. 13:207
61. Larsson SC, Orsini N. 2011. Coffee consumption and risk of stroke: A dose-response meta-analysis of prospective studies. Am. J. Epidemiol. 174:993-1001
62. Larsson SC, Wolk A. 2007. Coffee consumption and risk of liver cancer: Ameta-analysis. Gastroenterology 132:1740-45
63. Lee DR, Lee J, Rota M, Lee J, Ahn HS, et al. 2014. Coffee consumption and risk of fractures: A systematic review and dose-response meta-analysis. Bone 63:20-28
64. Lee YH, Bae SC, Song GG. 2014. Coffee or tea consumption and the risk of rheumatoid arthritis: A meta-analysis. Clin. Rheumatol. 33:1575-83
65. Li G, Ma D, Zhang Y, Zheng W, Wang P. 2013. Coffee consumption and risk of colorectal cancer: A meta-analysis of observational studies. Public Health Nutr. 16:346-57
66. Li J, Zhao H, Song JM, Zhang J, Tang YL, Xin CM. 2015. A meta-analysis of risk of pregnancy loss and caffeine and coffee consumption during pregnancy. Int. J. Gynaecol. Obstet. 130:116-22
67. Li L, Gan Y, Wu C, Qu X, Sun G, Lu Z. 2015. Coffee consumption and the risk of gastric cancer: A meta-analysis of prospective cohort studies. BMC Cancer 15:733
68. Li S, Dai Z, Wu Q. 2015. Effect of coffee intake on hip fracture: A meta-analysis of prospective cohort studies. Nutr. J. 14:38
69. Li XJ, Ren ZJ, Qin JW, Zhao JH, Tang JH, et al. 2013. Coffee consumption and risk of breast cancer: An up-to-date meta-analysis. PLOS ONE 8:e52681
70. Li XL, Xu JH. 2013. Coffee consumption and hip fracture risk: A meta-analysis. J. Nutr. Sci. 2:e23
71. Li YM, Peng J, Li LZ. 2016. Coffee consumption associated with reduced risk of oral cancer: A metaanalysis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 121:381-89
72. Li ZX, Gao ZL, Wang JN, Guo QH. 2016. Maternal coffee consumption during pregnancy and neural tube defects in offspring: A meta-analysis. Fetal Pediatr. Pathol. 35:1-9
73. Lippi G, Mattiuzzi C, Franchini M. 2015. Venous thromboembolism and coffee: Critical review and meta-analysis. Ann. Transl. Med. 3:152
74. Liu F, Wang X, Wu G, Chen L, Hu P, et al. 2015. Coffee consumption decreases risks for hepatic fibrosis and cirrhosis: A meta-analysis. PLOS ONE 10:e0142457
75. Liu H, Hu GH, Wang XC, Huang TB, Xu L, et al. 2015. Coffee consumption and prostate cancer risk: A meta-analysis of cohort studies. Nutr. Cancer 67:392-400
76. Liu H, Hua Y, Zheng X, Shen Z, Luo H, et al. 2015. Effect of coffee consumption on the risk of gastric cancer: A systematic review and meta-analysis of prospective cohort studies. PLOS ONE 10:e0128501
77. Liu H, Yao K, Zhang W, Zhou J, Wu T, He C. 2012. Coffee consumption and risk of fractures: A meta-analysis. Arch. Med. Sci. 8:776-83
78. Liu J, Shen B, Shi M, Cai J. 2016. Higher caffeinated coffee intake is associated with reduced malignant melanoma risk: A meta-analysis study. PLOS ONE 11:e0147056
79. Liu QP, Wu YF, Cheng HY, Xia T, Ding H, et al. 2016. Habitual coffee consumption and risk of cognitive decline/dementia: A systematic review and meta-analysis of prospective cohort studies. Nutrition 32:628-36
80. Liu R, Guo X, Park Y, Huang X, Sinha R, et al. 2012. Caffeine intake, smoking, and risk of Parkinson disease in men and women. Am. J. Epidemiol. 175:1200-7
81. Lu Y, Zhai L, Zeng J, Peng Q, Wang J, et al. 2014. Coffee consumption and prostate cancer risk: An updated meta-analysis. Cancer Causes Control 25:591-604
82. Ludwig IA, Clifford MN, Lean ME, Ashihara H, Crozier A. 2014. Coffee: Biochemistry and potential impact on health. Food Funct. 5:1695-717
83. Malerba S, Galeone C, Pelucchi C, Turati F, Hashibe M, et al. 2013. A meta-analysis of coffee and tea consumption and the risk of glioma in adults. Cancer Causes Control 24:267-76
84. Malerba S, Turati F, Galeone C, Pelucchi C, Verga F, et al. 2013. A meta-analysis of prospective studies of coffee consumption and mortality for all causes, cancers and cardiovascular diseases. Eur. J. Epidemiol. 28:527-39
85. Martini D, Del Bo C, Tassotti M, Riso P, Del Rio D, et al. 2016. Coffee consumption and oxidative stress: A review of human intervention studies. Molecules 21:979
86. Marventano S, Salomone F, Godos J, Pluchinotta F, Del Rio D, et al. 2016. Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: A systematic review and meta-analysis of observational studies. Clin. Nutr. 35:1269-81
87. Meng S, Cao J, Feng Q, Peng J, Hu Y. 2013. Roles of chlorogenic acid on regulating glucose and lipids metabolism: A review. Evid. Based Complement. Altern. Med. 2013:801457
88. Mesas AE, Leon-Munoz LM, Rodriguez-Artalejo F, Lopez-Garcia E. 2011. The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: A systematic review and meta-analysis. Am. J. Clin. Nutr. 94:1113-26
89. Milne E, Royle JA, Bennett LC, de Klerk NH, Bailey HD, et al. 2011. Maternal consumption of coffee and tea during pregnancy and risk of childhood ALL: Results from an Australian case-control study. Cancer Causes Control 22:207-18
90. Moco S, Martin FP, Rezzi S. 2012. Metabolomics view on gut microbiome modulation by polyphenolrich foods. J. Proteome Res. 11:4781-90
91. Moreira AS, Nunes FM, Domingues MR, Coimbra MA. 2012. Coffee melanoidins: Structures, mechanisms of formation and potential health impacts. Food Funct. 3:903-15
92. Mostofsky E, Rice MS, Levitan EB, Mittleman MA. 2012. Habitual coffee consumption and risk of heart failure: A dose-response meta-analysis. Circ. Heart Fail. 5:401-5
93. Mulak A, Bonaz B. 2015. Brain-gut-microbiota axis in Parkinson's disease. World J. Gastroenterol. 21:10609-20
94. Myers MG, Basinski A. 1992. Coffee and coronary heart disease. Arch. Intern. Med. 152:1767-72
95. Nehlig A. 2016. Effects of coffee/caffeine on brain health and disease: What should I tell my patients? Pract. Neurol. 16:89-95
96. Nie K, Xing Z, Huang W, Wang W, Liu W. 2016. Coffee intake and risk of pancreatic cancer: An updated meta-analysis of prospective studies. Minerva Med. 107:270-78
97. Noordzij M, Uiterwaal CS, Arends LR, Kok FJ, Grobbee DE, Geleijnse JM. 2005. Blood pressure response to chronic intake of coffee and caffeine: A meta-analysis of randomized controlled trials. J. Hypertens. 23:921-28
98. Ouyang Z, Wang Z, Jin J. 2014. Association between tea and coffee consumption and risk of laryngeal cancer: A meta-analysis. Int. J. Clin. Exp. Med. 7:5192-200
99. Palatini P, Ceolotto G, Ragazzo F, Dorigatti F, Saladini F, et al. 2009. CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension. J. Hypertens. 27:1594-601
100. Pan MH, Tung YC, Yang G, Li S, Ho CT. 2016. Molecular mechanisms of the anti-obesity effect of bioactive compounds in tea and coffee. Food Funct. 7:4481-91
101. Park CH, Myung SK, Kim TY, Seo HG, Jeon YJ, et al. 2010. Coffee consumption and risk of prostate cancer: A meta-analysis of epidemiological studies. BJU Int. 106:762-69
102. Park KY, Kim HJ, Ahn HS, Kim SH, Park EJ, et al. 2016. Effects of coffee consumption on serum uric acid: Systematic review and meta-analysis. Semin. Arthritis Rheum. 45:580-86
103. Qi H, Li S. 2014. Dose-response meta-analysis on coffee, tea and caffeine consumption with risk of Parkinson's disease. Geriatr. Gerontol. Int. 14:430-39
104. Ran HQ, Wang JZ, Sun CQ. 2016. Coffee consumption and pancreatic cancer risk: An update metaanalysis of cohort studies. Pak. J. Med. Sci. 32:253-59
105. Ranheim T, Halvorsen B. 2005. Coffee consumption and human health-beneficial or detrimental? Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and type 2 diabetes mellitus. Mol. Nutr. Food Res. 49:274-84
106. Rhee J, Kim R, Kim Y, Tam M, Lai Y, et al. 2015. Maternal caffeine consumption during pregnancy and risk of low birth weight: A dose-response meta-analysis of observational studies. PLOS ONE 10:e0132334
107. Saab S, Mallam D, Cox GA 2nd, Tong MJ. 2014. Impact of coffee on liver diseases: A systematic review. Liver Int. 34:495-504
108. Sang LX, Chang B, Li XH, Jiang M. 2013. Consumption of coffee associated with reduced risk of liver cancer: A meta-analysis. BMC Gastroenterol. 13:34
109. Santos C, Costa J, Santos J, Vaz-Carneiro A, Lunet N. 2010. Caffeine intake and dementia: Systematic review and meta-analysis. J. Alzheimers Dis. 20(Suppl. 1):S187-204
110. Shaffer EA. 2006. Gallstone disease: Epidemiology of gallbladder stone disease. Best Pract. Res. Clin. Gastroenterol. 20:981-96
111. Shang F, Li X, Jiang X. 2016. Coffee consumption and risk of the metabolic syndrome: A meta-analysis. Diabetes Metab. 42:80-87
112. Shen Z, Liu H, Cao H. 2015. Coffee consumption and risk of gastric cancer: An updated meta-analysis. Clin. Res. Hepatol. Gastroenterol. 39:245-53
113. Sheng J, Qu X, Zhang X, Zhai Z, Li H, et al. 2014. Coffee, tea, and the risk of hip fracture: Ameta-analysis. Osteoporos. Int. 25:141-50
114. Shimamoto T, Yamamichi N, Kodashima S, Takahashi Y, Fujishiro M, et al. 2013. No association of coffee consumption with gastric ulcer, duodenal ulcer, reflux esophagitis, and non-erosive reflux disease: A cross-sectional study of 8, 013 healthy subjects in Japan. PLOS ONE 8:e65996
115. Sofi F, Conti AA, Gori AM, Eliana Luisi ML, Casini A, et al. 2007. Coffee consumption and risk of coronary heart disease: A meta-analysis. Nutr. Metab. Cardiovasc. Dis. 17:209-23
116. Steevens J, Schouten LJ, Verhage BA, Goldbohm RA, van den Brandt PA. 2007. Tea and coffee drinking and ovarian cancer risk: Results from the Netherlands Cohort Study and a meta-analysis. Br. J. Cancer 97:1291-94
117. Steffen M, Kuhle C, Hensrud D, Erwin PJ, Murad MH. 2012. The effect of coffee consumption on blood pressure and the development of hypertension: A systematic review andmeta-analysis. J. Hypertens. 30:2245-54
118. Tang N, Wu Y, Ma J, Wang B, Yu R. 2010. Coffee consumption and risk of lung cancer: Ameta-analysis. Lung Cancer 67:17-22
119. Tang N, Zhou B, Wang B, Yu R. 2009. Coffee consumption and risk of breast cancer: A metaanalysis. Am. J. Obstet. Gynecol. 200:290.e1-9
120. Thomopoulos TP, Ntouvelis E, Diamantaras AA, Tzanoudaki M, Baka M, et al. 2015. Maternal and childhood consumption of coffee, tea and cola beverages in association with childhood leukemia: A metaanalysis. Cancer Epidemiol. 39:1047-59
121. Tian C, Wang W, Hong Z, Zhang X. 2013. Coffee consumption and risk of colorectal cancer: A doseresponse analysis of observational studies. Cancer Causes Control 24:1265-68
122. Timms JA, Relton CL, Rankin J, Strathdee G, Mc Kay JA. 2016.DNAmethylation as a potential mediator of environmental risks in the development of childhood acute lymphoblastic leukemia. Epigenomics 8:519-36
123. Turati F, Galeone C, Edefonti V, Ferraroni M, Lagiou P, et al. 2012. A meta-analysis of coffee consumption and pancreatic cancer. Ann. Oncol. 23:311-18
124. Turati F, Galeone C, La Vecchia C, Garavello W, Tavani A. 2011. Coffee and cancers of the upper digestive and respiratory tracts: Meta-analyses of observational studies. Ann. Oncol. 22:536-44
125. Vitaglione P, Fogliano V, Pellegrini N. 2012. Coffee, colon function and colorectal cancer. Food Funct. 3:916-22
126. Wang J, Li X, Zhang D. 2016. Coffee consumption and the risk of cutaneous melanoma: Ameta-analysis. Eur. J. Nutr. 55:1317-29
127. Wang L, Shen X, Wu Y, Zhang D. 2016. Coffee and caffeine consumption and depression: A meta-analysis of observational studies. Aust. N. Z. J. Psychiatry 50:228-42
128. Wang S, Zhang Y, Mao Z, He X, Zhang Q, Zhang D. 2014. A meta-analysis of coffee intake and risk of urolithiasis. Urol. Int. 93:220-28
129. Wang Y, Yu X, Wu Y, Zhang D. 2012. Coffee and tea consumption and risk of lung cancer: A doseresponse analysis of observational studies. Lung Cancer 78:169-70
130. Welsh EJ, Bara A, Barley E, Cates CJ. 2010. Caffeine for asthma. Cochrane Database Syst. Rev. 1:CD001112
131. World Health Organization. Population nutrient intake goals for preventing diet-related chronic diseases. http://www.who.int/nutrition/topics/5-population-nutrient/en/. Accessed November 2015. Geneva:WHO
132. Wu JN, Ho SC, Zhou C, Ling WH, Chen WQ, et al. 2009. Coffee consumption and risk of coronary heart diseases: A meta-analysis of 21 prospective cohort studies. Int. J. Cardiol. 137:216-25
133. Wu L, Sun D, He Y. 2017. Coffee intake and the incident risk of cognitive disorders: A dose-response meta-analysis of nine prospective cohort studies. Clin. Nutr. 36(3):730-36
134. Wu W, Tong Y, Zhao Q, Yu G, Wei X, Lu Q. 2015. Coffee consumption and bladder cancer: A metaanalysis of observational studies. Sci. Rep. 5:9051
135. Xie F, Wang D, Huang Z, Guo Y. 2014. Coffee consumption and risk of gastric cancer: A large updated meta-analysis of prospective studies. Nutrients 6:3734-46
136. Xie Y, Huang S, He T, Su Y. 2016. Coffee consumption and risk of gastric cancer: An updated metaanalysis. Asia Pac. J. Clin. Nutr. 25:578-88
137. Xie Y, Qin J, Nan G, Huang S, Wang Z, Su Y. 2016. Coffee consumption and the risk of lung cancer: An updated meta-analysis of epidemiological studies. Eur. J. Clin. Nutr. 70:199-206
138. Xu C, Zhang C, Wang XL, Liu TZ, Zeng XT, et al. 2015. Self-fluidmanagement in prevention of kidney stones: A PRISMA-compliant systematic review and dose-response meta-analysis of observational studies. Medicine 94:e1042
139. Yang TO, Crowe F, Cairns BJ, Reeves GK, Beral V. 2015. Tea and coffee and risk of endometrial cancer: Cohort study and meta-analysis. Am. J. Clin. Nutr. 101:570-78
140. Yew YW, Lai YC, Schwartz RA. 2016. Coffee consumption and melanoma: A systematic review and meta-analysis of observational studies. Am. J. Clin. Dermatol. 17:113-23
141. Yu X, Bao Z, Zou J, Dong J. 2011. Coffee consumption and risk of cancers: A meta-analysis of cohort studies. BMC Cancer 11:96
142. Zeegers MP, Tan FE, Goldbohm RA, van den Brandt PA. 2001. Are coffee and tea consumption associated with urinary tract cancer risk? A systematic review and meta-analysis. Int. J. Epidemiol. 30:353-62
143. Zeng SB, Weng H, Zhou M, Duan XL, Shen XF, Zeng XT. 2015. Long-term coffee consumption and risk of gastric cancer: A PRISMA-compliant dose-response meta-analysis of prospective cohort studies. Medicine 94:e1640
144. Zhang X, Albanes D, Beeson WL, van den Brandt PA, Buring JE, et al. 2010. Risk of colon cancer and coffee, tea, and sugar-sweetened soft drink intake: Pooled analysis of prospective cohort studies. J. Natl. Cancer Inst. 102:771-83
145. Zhang Y, Lee ET, Cowan LD, Fabsitz RR, Howard BV. 2011. Coffee consumption and the incidence of type 2 diabetes in men and women with normal glucose tolerance: The Strong Heart Study. Nutr.Metab. Cardiovasc. Dis. 21:418-23
146. Zhang Y, Wang X, Cui D. 2015. Association between coffee consumption and the risk of oral cancer: A meta-analysis of observational studies. Int. J. Clin. Exp. Med. 8:11657-65
147. Zhang Y, Yang T, Zeng C, Wei J, Li H, et al. 2016. Is coffee consumption associated with a lower risk of hyperuricaemia or gout? A systematic review and meta-analysis. BMJ Open 6:e009809
148. Zhang YP, Li WQ, Sun YL, Zhu RT, Wang WJ. 2015. Systematic review with meta-analysis: Coffee consumption and the risk of gallstone disease. Aliment. Pharmacol. Ther. 42:637-48
149. Zhao Y, Wu K, Zheng J, Zuo R, Li D. 2015. Association of coffee drinking with all-cause mortality: A systematic review and meta-analysis. Public Health Nutr. 18:1282-91
150. Zheng JS, Yang J, Fu YQ, Huang T, Huang YJ, Li D. 2013. Effects of green tea, black tea, and coffee consumption on the risk of esophageal cancer: A systematic review and meta-analysis of observational studies. Nutr. Cancer 65:1-16
151. Zhong S, Chen W, Yu X, Chen Z, Hu Q, Zhao J. 2014. Coffee consumption and risk of prostate cancer: An up-to-date meta-analysis. Eur. J. Clin. Nutr. 68:330-37
152. Zhou J, Zhou S, Zeng S. 2013. Experimental diabetes treated with trigonelline: Effect on ? cell and pancreatic oxidative parameters. Fundam. Clin. Pharmacol. 27:279-87
153. Zhou Q, Luo ML, Li H, Li M, Zhou JG. 2015. Coffee consumption and risk of endometrial cancer: A dose-response meta-analysis of prospective cohort studies. Sci. Rep. 5:13410
154. Zhou Y, Tian C, Jia C. 2012. A dose-response meta-analysis of coffee consumption and bladder cancer. Prev. Med. 55:14-22
155. Zuchinali P, Ribeiro PA, Pimentel M, da Rosa PR, Zimerman LI, Rohde LE. 2016. Effect of caffeine on ventricular arrhythmia: A systematic review and meta-analysis of experimental and clinical studies. Europace 18:257-66
156. Zulli A, Smith RM, Kubatka P, Novak J, Uehara Y, et al. 2016. Caffeine and cardiovascular diseases: Critical review of current research. Eur. J. Nutr. 55:1331-43